Why is Bank of Baroda (DIFC Branch) pursuing a forgery-focused trial against Mr. Bavaguthu Raghuram Shetty in CFI 043/2020?
The litigation centers on a complex multi-party debt recovery claim initiated by Bank of Baroda (DIFC Branch) against several corporate entities, including Neo Pharma LLC, NMC Healthcare LLC, and New Medical Centre LLC, alongside the Fourth Defendant, Mr. Bavaguthu Raghuram Shetty. The core of the dispute involves the enforceability of a Personal Guarantee dated 14 September 2017, which the Bank alleges was executed by Mr. Shetty to secure banking facilities. Mr. Shetty has contested the validity of this instrument, leading to a fundamental factual dispute over the authenticity of his signature.
The stakes involve the liability of the Fourth Defendant for the underlying corporate debt, which hinges entirely on the forensic determination of whether the signature on the guarantee and associated banking documents is genuine or fraudulent. This case represents a significant chapter in the broader recovery efforts following the financial restructuring of the NMC group. Previous procedural developments in this matter include:
BANK OF BARODA v NEO PHARMA [2020] DIFC CFI 043 — Procedural non-compliance in pleading amendments (07 March 2020)
BANK OF BARODA v NEO PHARMA [2020] DIFC CFI 043 — Alternative service via email (08 June 2020)
BANK OF BARODA v NEO PHARMA [2020] DIFC CFI 043 — Alternative service via email (11 July 2020)
BANK OF BARODA v NEO PHARMA [2020] DIFC CFI 043 — Amendment of pleadings for non-payment (18 August 2020)
BANK OF BARODA v NEO PHARMA [2020] DIFC CFI 043 — Interim stay of proceedings pending ADGM administration (06 December 2020)
Which judge presided over the 29 August 2024 consent order in the DIFC Court of First Instance?
The consent order was issued by Justice Wayne Martin, sitting in the DIFC Court of First Instance. Justice Martin has been actively managing the procedural progression of CFI 043/2020, including the specific directive to bifurcate the trial to address the forgery allegations as a preliminary issue.
What were the specific procedural undertakings agreed upon by the Claimant and the Fourth Defendant regarding original document handling?
The parties, recognizing the sensitivity of the forensic evidence required to prove or disprove the forgery, entered into strict undertakings regarding the physical integrity of the documents. The court recorded the following:
the solicitors for each of the Claimant and the Fourth Defendant undertaking to the Court to use their best endeavors to protect any original documents disclosed by the opposing party from harm, to ensure that all such originals are only handled by persons wearing gloves, and to return such documents as soon as they are no longer required by the party’s expert witness.
These undertakings reflect the high evidentiary standard required when challenging the authenticity of a signature in a commercial banking context, where the physical state of the paper and ink is paramount for expert analysis.
What was the precise legal question Justice Wayne Martin sought to resolve by limiting the scope of the trial in CFI 043/2020?
The court was tasked with determining whether the trial should proceed on all issues of liability and quantum, or whether it should be narrowed to address the threshold question of the Fourth Defendant’s signature. By his Order with Reasons dated 11 March 2024, Justice Martin determined that the most efficient path for the litigation was to isolate the forgery allegation. The legal question was whether the Personal Guarantee dated 14 September 2017 was a valid, binding instrument or a forgery, as the answer to this question would potentially dispose of the claim against the Fourth Defendant entirely, thereby avoiding unnecessary litigation on other complex commercial issues.
How did Justice Wayne Martin exercise his case management powers to structure the forgery trial?
Justice Martin utilized his broad case management powers under the Rules of the DIFC Courts (RDC) to bifurcate the proceedings. By isolating the forgery issue, the court ensured that the parties’ resources—and the court’s time—would be focused on the primary factual hurdle before addressing the broader, more complex issues of debt recovery and corporate liability. The court’s reasoning for this approach is summarized in the order:
UPON the Court ruling by its Order with Reasons of Justice Wayne Martin dated 11 March 2024 that there should be a trial limited to the issue of whether the Fourth Defendant’s signature on his Personal Guarantee dated 14 September 2017 and the associated banking documents are Forgeries.
By mandating this structure, the court effectively created a "mini-trial" focused on forensic evidence, which necessitates the strict handling protocols for original documents agreed upon by the parties.
Which specific RDC rules and judicial directives govern the filing of witness statements in this DIFC litigation?
The procedural requirements for witness statements in the DIFC Courts are primarily governed by Part 28 of the Rules of the DIFC Courts (RDC). In this specific instance, the timeline for the Fourth Defendant’s witness statement was not merely a matter of standard practice but was dictated by the Case Management Order of Justice Wayne Martin dated 12 August 2024. The consent order of 29 August 2024 serves to formalize the compliance deadline for the Fourth Defendant, ensuring that the evidentiary record is complete prior to the commencement of the forgery-focused trial.
How does the court’s reliance on expert witness testimony influence the procedural requirements for document disclosure?
The court’s reliance on expert testimony, as referenced in the undertakings, necessitates a higher standard of care for document disclosure than is typical in standard commercial litigation. Because the authenticity of the signature is the central issue, the "original documents" are the primary evidence. The court’s requirement that these documents be handled with gloves and returned promptly to the opposing party once the expert has finished their analysis is a direct application of the court’s duty to ensure a fair trial under the RDC, preventing any potential claims of document tampering or degradation that could prejudice the forensic outcome.
What was the final disposition regarding the Fourth Defendant’s witness statement and costs?
The court issued a consent order confirming the following:
1. The Fourth Defendant was ordered to file and serve his Witness Statement by no later than 4pm GST on 9 August 2024.
2. There was no order as to costs, meaning each party bears their own legal expenses incurred in relation to this specific procedural application.
What are the wider implications for practitioners handling forgery allegations in the DIFC?
This case serves as a template for practitioners managing high-stakes forgery allegations. It demonstrates the court’s preference for bifurcating trials to resolve threshold issues of document authenticity before proceeding to the merits of debt recovery. Practitioners must anticipate that when forgery is raised, the court will likely impose strict, forensic-level protocols for the handling of original documents. Failure to adhere to these protocols or to meet court-mandated deadlines for witness statements can result in significant procedural friction, as evidenced by the series of case management orders issued by Justice Martin throughout this litigation.
Where can I read the full judgment in Bank of Baroda (DIFC Branch) v (1) Neo Pharma LLC (2) Nmc Healthcare LLC (3) New Medical Centre LLC (4) Mr. Bavaguthu Raghuram Shetty [2024] DIFC CFI 043?
The full text of the consent order dated 29 August 2024 can be accessed via the DIFC Courts website: https://www.difccourts.ae/rules-decisions/judgments-orders/court-first-instance/cfi-0432020-bank-baroda-difc-branch-v-1-neo-pharma-llc-2-nmc-healthcare-llc-3-new-medical-centre-llc-4-mr-bavaguthu-raghuram-she-5 or via the CDN link: https://littdb.sfo2.cdn.digitaloceanspaces.com/litt/AE/DIFC/judgments/court-first-instance/DIFC_CFI-043-2020_20240829.txt
Cases referred to in this judgment:
| Case | Citation | How used |
|---|---|---|
| Bank of Baroda v Neo Pharma | [2020] DIFC CFI 043 | Primary case file |
Legislation referenced:
- Rules of the DIFC Courts (RDC) Part 28 (Witness Statements)
- Rules of the DIFC Courts (RDC) Part 4 (Court’s Case Management Powers)